FLIBANSERIN: A HAPPY ENDING SOLUTION TO HYPOACTIVE SEXUAL DESIRE DISORDER Journal title: Journal of Drug Delivery and Therapeutics Authors: Dick B. S. Brashier Subject(s):
Modeling and interactions analysis of the novel antagonist agent flibanserin with 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor as a HSDD treatment in premenopausal women Journal title: Eurasian Chemical Communications Authors: Mehdi Nabati Subject(s): Chemistry, Multidisciplinary, Chemistry, Organic
HPLC Method Development and Validation: For Simultaneous Determination of Flibanserin and Caffeine Journal title: Open Access Journal of Pharmaceutical Research Authors: Sharma P, Dahiya M, Wakode S* and Rani R Subject(s): Pharmaceutical science
